US FDA, NIH support projects advancing regulatory science
This article was originally published in SRA
Executive Summary
The US National Institutes of Health and the Food and Drug Administration have together committed financial support for four projects in regulatory science that are expected to better inform scientists and regulatory reviewers about medical product safety, and improve the evaluation and availability of new medical products to the community1.